A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...

CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

High-protein yogurt brand Oikos is expanding beyond the dairy aisle with protein shakes geared to GLP-1 users, Danone North ...

Donald Trump has vowed to cut the US’s globally high drug prices by as much as 80 per cent with an executive order that seeks to force other countries to pay more for their medicines.

Executive order says if companies and the government don’t align on tying U.S. drug prices to other countries, the ...

Novo Nordisk maintained Wegovy's unique approval for cardiovascular event prevention. This information follows U.S. drug approval and data presented at an obesity congress, despite CVS Health's recent ...

Novo Nordisk has potential with a 27% upside, strong market shares, and high ROI strategies. See why we recommend a buy on ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...